Previous 10 | Next 10 |
home / stock / rhhby / rhhby news
- Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit of novel therapies - - Multi-year research effort aims to optimize and accelerate each companyȁ...
2023-11-20 12:54:00 ET More on COVID-19 test makers Following The Q4 Results, Becton, Dickinson and Company Is Still A Hold Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24 Becton, Dickinson and Company (BDX) Q4 2023 Ea...
Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges PR Newswire The LightCycler PRO System is designed to be the most advanced qPCR technology for both clinical diagnostics and research. ...
2023-11-19 12:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Perfectly Priced Healthcare Giant Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise ...
2023-11-19 09:56:29 ET Summary WisdomTree International Quality Dividend Growth Fund selects ex-North America dividend stocks with quality and expected earnings growth characteristics. The fund is well-diversified across countries, sectors, and holdings, with a focus on Europe. ...
2023-11-17 13:08:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The article embarks on a transformative journey through the biotech frontier, where the listed companies stand as titans reshaping healthcare norms. The first one’s strategic collabo...
2023-11-16 12:35:07 ET Summary Recursion Pharmaceuticals, Inc. proof-of-concept data, from the phase 2 SYCAMORE study using REC-994 for the treatment of patients with Cerebral Cavernous Malformation, expected in the 2nd half of 2024. Safety and preliminary efficacy data, from the ...
2023-11-14 08:45:50 ET Palm Beach, FL – November 14, 2023 – FinancialNewsMedia.com News Commentary – Oncology drugs include wide range of medications such as targeted therapies, chemotherapy agents, immunotherapies, and hormone therapies to treat cancer. The...
2023-11-09 06:54:33 ET More on AstraZeneca AstraZeneca: Revenue Softening Possible, Profits To Rise AstraZeneca: Buy This Blue-Chip Bargain For A Richer Retirement AstraZeneca: Hidden Gem Of The Pharma Sector Is A Great Buy Opportunity AstraZeneca lifts forec...
2023-11-07 17:07:59 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Ltd ADR Company Name:
RHHBY Stock Symbol:
OTCMKTS Market:
Roche Holding Ltd ADR Website:
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
– Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) – – Safety data were consistent with the known safety profile for Susvimo in people...